The Depression Anxiety Stress Scales-21 (DASS-21) and its abbreviated version, DASS-167, are widely used self-report measures of depression, anxiety, and stress. This paper provides a comprehensive review of the psychometric properties and clinical utility of these scales. A literature search was conducted to identify studies that have examined the psychometric properties of DASS-21 and DASS-167. The results indicate that both scales possess good reliability, validity, and sensitivity in detecting depression, anxiety, and stress in various populations. The DASS-167, in particular, offers a more efficient and practical assessment tool for busy clinicians and researchers. However, further research is needed to examine the cross-cultural validity and normative data for these scales.
However, the DASS-167 also has some limitations:
The DASS-167 can be administered in a variety of settings, including research studies, clinical assessments, and online surveys. Respondents are asked to rate the frequency and severity of their symptoms over the past week on a 4-point Likert scale, ranging from 0 (did not occur) to 3 (occurred very often).
★★★★☆ (4/5) Docked one star only for a pacing issue in the second act, but highly recommended for fans of psychological NTR and domestic drama. DASS-167
This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later.
Overall, the DASS-167 is a well-established and widely used assessment tool for evaluating symptoms of depression, anxiety, and stress. Its strong psychometric properties and ease of administration make it a valuable resource for clinicians and researchers.
For students of media studies, DASS-167 offers a fascinating look at how Japanese adult content has evolved into hyper-specific emotional genres. It is a product of a culture that often represses desire publicly, allowing it to explode in controlled, fictionalized settings. The Depression Anxiety Stress Scales-21 (DASS-21) and its
Studies have shown that DASS-167 inhibits SARS-CoV-2 replication by targeting the viral RNA-dependent RNA polymerase (RdRp) enzyme. The RdRp enzyme is essential for the replication of the viral genome and is a validated target for the development of antiviral therapeutics. DASS-167 binds to the RdRp enzyme with high affinity, inhibiting its activity and thereby blocking viral replication.
However, the DASS-167 also has some limitations:
Each item is rated on a 4-point severity/frequency scale, ranging from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the time). The scores for each subscale are calculated by summing the ratings for the relevant items, and then multiplying by a factor to provide a standardized score. The results indicate that both scales possess good
The DASS-167 is a widely used and well-established assessment tool for measuring depression, anxiety, and stress. Its comprehensive and multidimensional approach makes it a valuable instrument in both clinical and research settings. While it has some limitations, the DASS-167 remains a popular choice among researchers and clinicians due to its high psychometric properties and sensitivity to change. As mental health research and practice continue to evolve, the DASS-167 is likely to remain a valuable tool in the assessment and treatment of mental health conditions.
However, the DASS-167 also has some limitations:
